Todd Shegog

Insider Reports History

Entity
Individual
Location
200 Sidney Street, Suite 320, C/O Synlogic, Inc., Cambridge, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd Shegog:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Director Stock Option (Right to Buy) 44.7K $321K $7.19 Jun 5, 2024 Direct
Forma Therapeutics Holdings, Inc. SVP, Chief Financial Officer Common Stock 0 $5.05 Oct 14, 2022 Direct
Forma Therapeutics Holdings, Inc. SVP, Chief Financial Officer Stock Option (Right to Buy) 0 Oct 14, 2022 Direct

Insider Reports Filed by Todd Shegog

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COGT Cogent Biosciences, Inc. Jun 5, 2024 1 $0 4 Jun 13, 2024 Director
COGT Cogent Biosciences, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
FMTX Forma Therapeutics Holdings, Inc. Oct 14, 2022 7 $0 4 Oct 14, 2022 SVP, Chief Financial Officer
COGT Cogent Biosciences, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
FMTX Forma Therapeutics Holdings, Inc. Feb 28, 2022 2 $0 4 Mar 2, 2022 SVP, Chief Financial Officer
FMTX Forma Therapeutics Holdings, Inc. Feb 23, 2022 1 -$55.6K 4 Feb 25, 2022 SVP, Chief Financial Officer